A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

February 24, 2022

Study Completion Date

February 24, 2022

Conditions
Narcolepsy
Interventions
DRUG

Transition from Xyrem to Xywav

This is a single-group non-interventional study where participant's transitioning from Xyrem to Xywav will be observed. Investigational product (IP) or drug support or requested changes to their medication will not be provided to participants by Jazz Pharmaceuticals. The Xyrem and Xywav that the participants will take will be provided by the participant's health care provider.

Trial Locations (1)

94304

Jazz Pharmaceuticals Clinical Site, Palo Alto

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY